MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
about
Decoding the usefulness of non-coding RNAs as breast cancer markersTumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.Small molecule therapeutics targeting F-box proteins in cancer.High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.The Role of MicroRNAs in the Chemoresistance of Breast Cancer.MicroRNA regulation of F-box proteins and its role in cancer.Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer.IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer.miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3.Elevated miR-301a expression indicates a poor prognosis for breast cancer patients.SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7.miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer.MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancerIntegrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome AtlasKnockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulationmiR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)
P2860
Q28069370-9B67186E-1C9C-4950-AC67-B542D44A07F7Q33618553-D3BF46B3-76BE-49A0-91AA-92DACC145DE9Q33733403-83139FC8-06A1-4F4D-8F17-648F4D7BDF2BQ36600976-0F78C82B-523B-496D-B202-9D005319247AQ37662154-402B52F0-D2D8-4D7E-999F-CBB6AAA07B2DQ37709281-6E11B0B1-7D64-4191-8D33-BF0E4EE0DACFQ38432397-DDD07D3B-2E2D-48D4-94A7-B83038555726Q38574546-F445D473-3714-4FE4-8029-958BCF88FF82Q38577492-927AF3C7-8F88-4EC6-9E6A-BD473880FBB5Q38790804-5347A2E1-F081-4B0F-B03D-78AA2974B419Q42041224-DF8000D7-A453-40DA-97CA-0A4E8D13BE4DQ46227416-552B4CAA-7070-46E9-A057-27658898969EQ47116282-CFAA4585-AF1B-4EB4-848C-5C336660F4FBQ47152080-F356E120-CD89-4009-A912-56BE822EBF0EQ48515407-912E6A17-AAF2-4DAD-8BF9-CB6C9A040E1DQ49357950-606BC085-4451-4238-B24D-BBB25CBCC029Q50129421-617193F6-8633-44AF-92CC-FDBE728A1570Q52655150-E2D90F44-4A3B-44A5-BE5C-3186C9602030Q53695419-910BAC76-933E-4F15-A7A6-0370F96E0F48Q55263047-C574140C-E8C8-422E-AE5F-635A5E71D7BCQ57118829-1A88B1B1-2F47-4701-A920-9FC7D7927CFCQ57174326-A44E20A6-ED75-4039-BA39-055C5EA414EEQ57474446-3296758E-5D74-41C8-9C6E-396F36A2FB52Q58725258-248DB045-29E9-42B2-8297-5E03FD29C676
P2860
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@ast
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@en
type
label
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@ast
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@en
prefLabel
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@ast
MiRNA-621 sensitizes breast ca ...... 11 and enhancing p53 activity.
@en
P2093
P2860
P356
P1433
P1476
MiRNA-621 sensitizes breast ca ...... O11 and enhancing p53 activity
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.96
P407
P577
2015-04-13T00:00:00Z